{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:26:29Z","timestamp":1787667989643,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH111-1R15"],"award-info":[{"award-number":["KMUH111-1R15"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH112-2R23"],"award-info":[{"award-number":["KMUH112-2R23"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH114-4M16"],"award-info":[{"award-number":["KMUH114-4M16"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH-DK(B)114002-1"],"award-info":[{"award-number":["KMUH-DK(B)114002-1"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH-DK(B)115004-1"],"award-info":[{"award-number":["KMUH-DK(B)115004-1"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH-DK(C)115001"],"award-info":[{"award-number":["KMUH-DK(C)115001"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC113B04"],"award-info":[{"award-number":["KMU-TC113B04"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC113A04"],"award-info":[{"award-number":["KMU-TC113A04"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12149-026-02230-z","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:02:27Z","timestamp":1779274947000},"page":"1098-1110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline FDG PET\/CT SUVmax predicts POD24 and progression-free survival in newly diagnosed follicular lymphoma"],"prefix":"10.1007","volume":"40","author":[{"given":"Yu-Chieh","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Jang","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yu","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Shiun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Ching","family":"Gau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-I","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Ping","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Mu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ching","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9884-9429","authenticated-orcid":false,"given":"Shih-Feng","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"1","key":"2230_CR1","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/S2352-3026(20)30365-3","volume":"8","author":"SF Barrington","year":"2021","unstructured":"Barrington SF, Trotman J. The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma. Lancet Haematol. 2021;8(1):e80\u201393.","journal-title":"Lancet Haematol"},{"issue":"20","key":"2230_CR2","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1002\/cncr.33772","volume":"127","author":"ME Juweid","year":"2021","unstructured":"Juweid ME, Mueller M, Alhouri A, MZ AR, Mottaghy FM. Positron emission tomography\/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update. Cancer. 2021;127(20):3727\u201341.","journal-title":"Cancer"},{"issue":"11","key":"2230_CR3","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1182\/blood.2021013437","volume":"139","author":"JP Leonard","year":"2022","unstructured":"Leonard JP. POD24 in follicular lymphoma: time to be wise. Blood. 2022;139(11):1609\u201310.","journal-title":"Blood"},{"issue":"1","key":"2230_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1182\/hematology.2024000662","volume":"2024","author":"P Mondello","year":"2024","unstructured":"Mondello P, Casulo C. The POD24 challenge: where do we go from here for early progressors? Hematol Am Soc Hematol Educ Program. 2024;2024(1):301\u20139.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"2230_CR5","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00277-024-06079-y","volume":"104","author":"X Li","year":"2025","unstructured":"Li X, Wang X. Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas. Ann Hematol. 2025;104(3):1427\u201342.","journal-title":"Ann Hematol"},{"issue":"12","key":"2230_CR6","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","volume":"37","author":"L Le Dortz","year":"2010","unstructured":"Le Dortz L, De Guibert S, Bayat S, Devillers A, Houot R, Rolland Y, et al. Diagnostic and prognostic impact of 18F-FDG PET\/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(12):2307\u201314.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2230_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.kjms.2014.11.012","volume":"31","author":"SF Cho","year":"2015","unstructured":"Cho SF, Chang CC, Liu YC, Chang CS, Hsiao HH, Liu TC, et al. Utilization of 18F-FDG PET\/CT as a staging tool in patients with newly diagnosed lymphoma. Kaohsiung J Med Sci. 2015;31(3):130\u20137.","journal-title":"Kaohsiung J Med Sci"},{"issue":"22","key":"2230_CR8","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1182\/blood-2017-11-816298","volume":"131","author":"AS Cottereau","year":"2018","unstructured":"Cottereau AS, Versari A, Luminari S, Dupuis J, Chartier L, Casasnovas RO, et al. Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA\/FIL study. Blood. 2018;131(22):2449\u201353.","journal-title":"Blood"},{"issue":"1","key":"2230_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3324\/haematol.2020.263194","volume":"107","author":"C Rossi","year":"2022","unstructured":"Rossi C, Tosolini M, Gravelle P, Pericart S, Kanoun S, Evrard S, et al. Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma. Haematologica. 2022;107(1):221\u201330.","journal-title":"Haematologica"},{"issue":"8","key":"2230_CR10","first-page":"3857","volume":"12","author":"X Wan","year":"2022","unstructured":"Wan X, Guo W, Wang X, Li J, Zhao Y, Feng X, et al. Improving the prognostic ability of PET\/CT SUVmax to identify follicular lymphoma with early treatment failure. Am J Cancer Res. 2022;12(8):3857\u201369.","journal-title":"Am J Cancer Res"},{"key":"2230_CR11","doi-asserted-by":"crossref","unstructured":"Chauhan A, Dreta B, Sackstein PE, Ahn J, Cheson BD. 891MO Role of baseline PET SUVmax in predicting early progression in follicular lymphoma (FL): A single-center retrospective analysis. Ann Oncol. 2020;31.(Suppl 4):S651.","DOI":"10.1016\/j.annonc.2020.08.009"},{"issue":"8","key":"2230_CR12","doi-asserted-by":"publisher","first-page":"e0272787","DOI":"10.1371\/journal.pone.0272787","volume":"17","author":"A Jona","year":"2022","unstructured":"Jona A, Kenyeres A, Barna S, Illes A, Simon Z. Clinical and biological prognostic factors in follicular lymphoma patients. PLoS ONE. 2022;17(8):e0272787.","journal-title":"PLoS ONE"},{"issue":"8","key":"2230_CR13","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1007\/s00330-022-08624-7","volume":"32","author":"Q Yang","year":"2022","unstructured":"Yang Q, Luo Y, Zhang Y, Zhang W, Zhou D, Li F, Baseline. [(18)F]FDG PET\/CT may predict the outcome of newly diagnosed follicular lymphoma in patients managed with initial watch-and-wait approach. Eur Radiol. 2022;32(8):5568\u201376.","journal-title":"Eur Radiol"},{"issue":"11","key":"2230_CR14","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1182\/blood.2020008243","volume":"139","author":"J Trotman","year":"2022","unstructured":"Trotman J, Pettitt AR. Is it time for PET-guided therapy in follicular lymphoma? Blood. 2022;139(11):1631\u201341.","journal-title":"Blood"},{"issue":"3","key":"2230_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.semnuclmed.2022.11.001","volume":"53","author":"L Zanoni","year":"2023","unstructured":"Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, et al. PET\/CT in Non-Hodgkin Lymphoma: An Update. Semin Nucl Med. 2023;53(3):320\u201351.","journal-title":"Semin Nucl Med"},{"issue":"6","key":"2230_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/MNM.0000000000001182","volume":"41","author":"O Kupik","year":"2020","unstructured":"Kupik O, Akin S, Tuncel M, Eren G, Turker A, Kars A, et al. Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement. Nucl Med Commun. 2020;41(6):540\u20139.","journal-title":"Nucl Med Commun"},{"issue":"6","key":"2230_CR17","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/bjh.19852","volume":"205","author":"D Albano","year":"2024","unstructured":"Albano D. (18)F-FDG PET\/CT impact in grade 3B follicular lymphoma. Br J Haematol. 2024;205(6):2134\u20135.","journal-title":"Br J Haematol"},{"issue":"1","key":"2230_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.annonc.2023.10.121","volume":"35","author":"AS Cottereau","year":"2024","unstructured":"Cottereau AS, Rebaud L, Trotman J, Feugier P, Nastoupil LJ, Bachy E, et al. Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial. Ann Oncol. 2024;35(1):130\u20137.","journal-title":"Ann Oncol"},{"key":"2230_CR19","doi-asserted-by":"publisher","first-page":"111632","DOI":"10.1016\/j.ejrad.2024.111632","volume":"178","author":"Q Yang","year":"2024","unstructured":"Yang Q, Zhang H, Zhang Y, Zhang W, Zhou D, Luo Y. Baseline (18)F-FDG PET\/CT may contribute to the determination of initial treatment strategy for newly diagnosed follicular lymphoma. Eur J Radiol. 2024;178:111632.","journal-title":"Eur J Radiol"},{"issue":"11","key":"2230_CR20","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.1016\/j.acra.2025.08.003","volume":"32","author":"X Wang","year":"2025","unstructured":"Wang X, Chen Y, Huang Y. Prognostic Value of 18F-FDG PET\/CT Parameters at Baseline and End of Treatment in Follicular Lymphoma: A Systematic Review and Meta-analysis. Acad Radiol. 2025;32(11):6840\u201356.","journal-title":"Acad Radiol"},{"issue":"23","key":"2230_CR21","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","volume":"33","author":"C Casulo","year":"2015","unstructured":"Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, et al. Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study. J Clin Oncol. 2015;33(23):2516\u201322.","journal-title":"J Clin Oncol"},{"issue":"11","key":"2230_CR22","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/ajh.24492","volume":"91","author":"MJ Maurer","year":"2016","unstructured":"Maurer MJ, Bachy E, Ghesquieres H, Ansell SM, Nowakowski GS, Thompson CA, et al. Early event status informs subsequent outcome in newly diagnosed follicular lymphoma. Am J Hematol. 2016;91(11):1096\u2013101.","journal-title":"Am J Hematol"},{"issue":"2","key":"2230_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1200\/JCO.18.00400","volume":"37","author":"C Sarkozy","year":"2019","unstructured":"Sarkozy C, Maurer MJ, Link BK, Ghesquieres H, Nicolas E, Thompson CA, et al. Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts. J Clin Oncol. 2019;37(2):144\u201352.","journal-title":"J Clin Oncol"},{"key":"2230_CR24","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.2147\/CMAR.S216445","volume":"11","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhao Z, Li J, Zhang B, Sang S, Wu Y, et al. Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET\/CT in patients with follicular lymphoma. Cancer Manag Res. 2019;11:6871\u201385.","journal-title":"Cancer Manag Res"},{"issue":"12","key":"2230_CR25","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00277-016-2800-1","volume":"95","author":"S Yuda","year":"2016","unstructured":"Yuda S, Maruyama D, Maeshima AM, Makita S, Kitahara H, Miyamoto KI, et al. Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era. Ann Hematol. 2016;95(12):2017\u201322.","journal-title":"Ann Hematol"},{"issue":"7","key":"2230_CR26","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3324\/haematol.2019.230649","volume":"105","author":"P Strati","year":"2020","unstructured":"Strati P, Ahmed MA, Fowler NH, Nastoupil LJ, Samaniego F, Fayad LE, et al. Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma. Haematologica. 2020;105(7):1907\u201313.","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"2230_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","volume":"44","author":"SF Barrington","year":"2017","unstructured":"Barrington SF, Kluge R. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):97\u2013110.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"30","key":"2230_CR28","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","volume":"34","author":"M Meignan","year":"2016","unstructured":"Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, et al. Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies. J Clin Oncol. 2016;34(30):3618\u201326.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2230_CR29","doi-asserted-by":"publisher","first-page":"e2017029","DOI":"10.4084\/mjhid.2017.029","volume":"9","author":"A Gallamini","year":"2017","unstructured":"Gallamini A, Borra A. FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management. Mediterr J Hematol Infect Dis. 2017;9(1):e2017029.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"2230_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/annonc\/mdn657","volume":"20","author":"A Noy","year":"2009","unstructured":"Noy A, Schoder H, Gonen M, Weissler M, Ertelt K, Cohler C, et al. The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Ann Oncol. 2009;20(3):508\u201312.","journal-title":"Ann Oncol"},{"issue":"26","key":"2230_CR31","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","volume":"31","author":"BK Link","year":"2013","unstructured":"Link BK, Maurer MJ, Nowakowski GS, Ansell SM, Macon WR, Syrbu SI, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource. J Clin Oncol. 2013;31(26):3272\u20138.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2230_CR32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1470-2045(18)30102-5","volume":"19","author":"S Huet","year":"2018","unstructured":"Huet S, Tesson B, Jais JP, Feldman AL, Magnano L, Thomas E, et al. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts. Lancet Oncol. 2018;19(4):549\u201361.","journal-title":"Lancet Oncol"},{"issue":"9","key":"2230_CR33","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","volume":"16","author":"A Pastore","year":"2015","unstructured":"Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, et al. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol. 2015;16(9):1111\u201322.","journal-title":"Lancet Oncol"},{"issue":"10","key":"2230_CR34","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/MNM.0b013e3282eff2d5","volume":"28","author":"JM Zijlstra","year":"2007","unstructured":"Zijlstra JM, Comans EF, van Lingen A, Hoekstra OS, Gundy CM, Willem Coebergh J, et al. FDG PET in lymphoma: the need for standardization of interpretation. An observer variation study. Nucl Med Commun. 2007;28(10):798\u2013803.","journal-title":"Nucl Med Commun"},{"issue":"11","key":"2230_CR35","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/S1470-2045(18)30618-1","volume":"19","author":"J Trotman","year":"2018","unstructured":"Trotman J, Barrington SF, Belada D, Meignan M, MacEwan R, Owen C, et al. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial. Lancet Oncol. 2018;19(11):1530\u201342.","journal-title":"Lancet Oncol"},{"issue":"15","key":"2230_CR36","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1182\/blood.2024026017","volume":"146","author":"E Mulvey","year":"2025","unstructured":"Mulvey E, Rutherford SC, Leonard JP. The future of follicular lymphoma management: strategies on the horizon. Blood. 2025;146(15):1792\u2013801.","journal-title":"Blood"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02230-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02230-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02230-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:43:26Z","timestamp":1787665406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02230-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2230"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02230-z","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Kaohsiung Medical University Hospital (IRB number: KMUHIRB-E(II)-20250348). Informed consent was not required due to the retrospective study design and the use of de-identified data.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}